Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel (RP)

Similar documents
Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel (RP) EZ

Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel 2 plus (RP2plus)

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus

Proficiency Testing Materials for use with FilmArray Panels

Lab Alert REMINDER: BioFire- FilmArray Respiratory Panel

PATHOGEN DETECTION WITH THE FILMARRAY

Potential Reimbursement CPT Codes

PAMET Continuing Education 2016

AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS

Proficiency Testing Materials for use with BioFire FilmArray Panels

Respiratory Pathogen Panel TEM-PCR Test Code:

FilmArray Respiratory Panel Quick Guide

MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels

Test Menu. Infectious Diseases Laboratory. Division of Infectious Diseases Department of Medicine

Rapid-VIDITEST. Influenza A+B

Syndromic Testing: The right test, the first time.

MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels

INFECTIOUS DISEASE. Page 2

Human Influenza A (Swine Flu) Rapid test

COLLECTION GUIDELINE FOR LABORATORY DIAGNOSIS OF COMMON VIRAL INFECTIONS

Molecular Diagnostics at Point of Care It s The Future Already. Ack!

Screening (and Diagnosis) of 15 Respiratory Viruses Using NAAT

Retrospective and Prospective Verification of the Cepheid Xpert Flu Assay

Evaluation of the BioFire FilmArray Respiratory Panel and the GenMark esensor Respiratory Viral Panel on Lower Respiratory Tract Specimens

Creating a User Defined Pneumonia-Specific Syndrome in ESSENCE. Preventive Medicine Directorate September 2016

Comparison of Two Multiplex Methods for Detection of Respiratory Viruses: FilmArray RP and xtag RVP

Rapid-VIDITEST. Influenza A

Rapid-VIDITEST Swine Flu

QUICK REFERENCE INSTRUCTIONS For use with Sofia only.

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

RESPIRATORY WATCH Week 3 (January 14 to January 20, 2018)*

Comparison of the eplex Respiratory Pathogen Panel with Laboratory Developed Real-

RESPIRATORY WATCH Week 2 (January 6, 2019 to January 12, 2019 )*

October Influenza Testing for the Season. Lauren Anthony, MD, MT(ASCP)SBB Medical Director, Allina Medical Laboratories

MENU PRODUCT MOLECULAR. International Product Listing. Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 26, 2018

M. Khanna and S. Visuri

INFINITI FLU A-sH1N1 Assay Directional Package Insert (DPI)

At the forefront of multiplex PCR

DiagCORE Respiratory Panel 2. Instructions for use PL /2018-EN

FOR IN VITRO DIAGNOSTIC USE

Line Listing and Specimen Collection. Module 5

M O L E C U L A R G E N E T I C S

QUICK REFERENCE INSTRUCTIONS

Alkaline Phosphatase, Bone Specific

Rapid Detection FAQs

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

S. Wesley Long, MD, PhD

Molecular Diagnostics at Point of Care When will we get there; and where is there anyway?

QUICK REFERENCE INSTRUCTIONS For use with Sofia and Sofia 2. Rx only

an inflammation of the bronchial tubes

Respiratory virus associated communityacquired pneumonia in Western Australian Children: case-control study

Influenza Weekly Surveillance Bulletin

Coordinate shipping to the Oregon State Public Health Lab through your local health department

TEST REQUEST INFORMATION- VIROLOGY

POC TESTING: COST V CONVENIENCE. Presented by: Jim Poggi Principal Tested Insights, LLC January 29, 2019

4. RED AND BLUE TOP COLLECTION SWABS WILL NO LONGER BE SUPPLIED FOR BACTERIAL CULTURE

Research Article The Epidemiology of Upper Respiratory Infections at a Tertiary Care Center: Prevalence, Seasonality, and Clinical Symptoms

and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs

Influenza A & B Screening

Likelihood that an unsubtypeable Influenza A result. in the Luminex xtag Respiratory Virus Panel. is indicative of novel A/H1N1 (swine-like) influenza

1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal swine Influenza A vir

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract

Comparison of Luminex NxTAG Respiratory Pathogen Panel and xtag Respiratory Viral Panel FAST Version 2 for the Detection of Respiratory Viruses

Redefine Performance. BD Veritor. System Revolutionizes Testing at the Point of Care. Fast. Streamlined Workflow Requires minimal hands-on time

New viruses causing respiratory tract infections. Eric C.J. Claas

Technical Bulletin No. 161

Next Generation Rapid Diagnostics

RealLine Mycoplasma genitalium Str-Format

Product # Kit Components

Healthy Kansans living in safe and sustainable environments.

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: INSTI HIV-1/HIV-2 Antibody Test Number: PQDx

Influenza Weekly Surveillance Bulletin

MICROBIOLOGICAL TESTING IN PICU

Upper...and Lower Respiratory Tract Infections

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Real-Time PCR Detects Viral Nucleic Acids in Universal Transport Medium (UTM-RT) with Flocked Swabs

From the Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis.

Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid

Pathogen Surveillance Program. DoD Global Respiratory. USAF School of Aerospace Medicine & Defense Health Agency

Dear Healthcare Provider, The information contained here may be very important to your practice. Please take a moment to review this document.

1. Introduction. The University of Hong Kong, Pokfulam, Hong Kong

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler

Received 4 December 2006/Returned for modification 4 April 2007/Accepted 17 June 2007

Influenza Weekly Surveillance Bulletin

The FDA s New Reclassification of Rapid Influenza Diagnostic Tests: Are you Prepared?

Standard Operating Procedure

Virology Proficiency Testing Program. Restricted Category Direct Antigen Detection

2017/18 Influenza Season Summary

INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)

Ontario Respiratory Pathogen Bulletin I

Molecular Diagnostics for Influenza & Other Respiratory Viruses

In the name of God. Respiratory Viruses. An Overview

ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015)

For Research Use Only Ver

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: SURE CHECK HIV 1/2 Assay Number: PQDx

Transcription:

Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel (RP) Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes quality standards for all laboratory testing to ensure the accuracy and reliability of patient test results, regardless of where the test is performed. The CLIA regulations include a requirement for verifying the performance specifications of unmodified, moderate complexity tests cleared or approved by the FDA. This document provides examples of procedures to assist your laboratory in developing a protocol for the verification of FilmArray RP performance on FilmArray 1.5, 2.0 and Torch Systems as required by CLIA. Two possible verification schemes, compatible with the FilmArray RP, have been designed. Each verification scheme provides positive and negative tests for each organism detected by the FilmArray RP using non-clinical specimens and may be easily modified or expanded to meet specific criteria. Day-to-day variation is evaluated by testing each sample on two separate days. To evaluate user-to-user variation, multiple laboratory technicians may test the same sample. In addition, testing patient samples for verification or to evaluate matrix effects on the performance of the FilmArray RP should be done under the guidance of the Laboratory Director, but is not described here. As per the CLIA regulation, the Laboratory Director is ultimately responsible for ensuring that verification procedures meet the appropriate standards for CLIA and applicable laboratory accrediting agencies. FilmArray Intended Use The FilmArray RP is a multiplexed nucleic acid test intended for use with FilmArray Systems for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of respiratory tract infections. The following organisms and subtypes are identified using the FilmArray RP: adenovirus, coronavirus 229E, coronavirus HKU1, coronavirus NL63, coronavirus OC43, human metapneumovirus, influenza A, influenza A subtype H1, influenza A subtype H3, influenza A subtype 2009 H1, influenza B, parainfluenza virus 1, parainfluenza virus 2, parainfluenza virus 3, parainfluenza virus 4, rhinovirus/enterovirus, respiratory syncytial virus, Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae. The complete intended use statement and additional information about the use of the FilmArray System can be found in the FilmArray Respiratory Panel Instruction Booklet. te: pneumoniae. Chlamydia pneumoniae is sometimes referred to as Chlamydophila 1 P a g e FLM1-PRT-0060-08 Technical te

Performance Verification: Overview Each procedure described below will generate multiple positive and negative results for each of the FilmArray Respiratory Panel (RP) assays. The procedures were developed using a Respiratory Verification Panel available from ZeptoMetrix Corporation, Buffalo, NY (part number NATRVP-IDI). Two different examples of performance verification procedures are described: (1) a Simple Protocol for the verification of the FilmArray RP performance on any FilmArray System and (2) a Viral Transport Media (VTM) Protocol that evaluates FilmArray RP performance when organisms are in a VTM sample matrix. A FilmArray System is defined as one or more FilmArray Instruments or modules connected to and controlled by a single computer system. If the laboratory director chooses not to perform the verification protocol on each individual instrument, it is advised that test replicates are evenly distributed among the instruments or modules. Performance verification protocols should be designed to take advantage of the multiplex nature of the FilmArray RP. Verification testing efficiency is maximized by evaluating multiple target organisms in a single test run. Clinical/patient specimens may be used in place of or in addition to the verification protocol examples described here in order to assess clinical sensitivity and sample matrix effects in the performance verification of the FilmArray RP. Table 1. Overview of Verification Protocols Verification Protocol Organisms per Pool a Number of Sample Pools Replicates per Sample Pool Pouches Required Expected Positive Results Expected Negative Results Approximate Days of Testing b Example 1: Simple protocol 2 or 3 7 4 28 4 per organism 24 per organism 6 Example 2: Viral Transport Medium (VTM) protocol 1 19 4 76 4 per organism 72 per organism 14 a Depending on the material used for verification, pooling of organisms may not be appropriate and the values in the table may need to be modified. b The approximate number of days for testing assumes a system configured with one instrument. Performance Verification: Materials The following materials may be used to perform verification procedures: Table 2. Materials needed for recommended verification protocols Material Part Number FilmArray RP Kit (30 tests) Control Organism BioFire Diagnostics,LLC RFIT-ASY-0124 ZeptoMetrix NATRVP-IDI a Transport Medium (e.g. Remel M4 Viral Transport Various media are appropriate Media) a Any appropriate source of organism may be used for verification of any or all of the assays in the FilmArray RP. However, when alternate organism sources are used (i.e. not the ZeptoMetrix NATRVP- IDI material), the sample volumes or pooling schemes suggested in the examples below may need to be adjusted. 2 P a g e FLM1-PRT-0060-08 Technical te

Performance Verification: Protocols Simple Protocol The Simple protocol utilizes samples prepared by pooling together either 2 or 3 different organisms (ZeptoMetrix NATRVP-IDI control organism). The proposed organism pooling scheme (Table 3) should be followed to obtain the expected number of positive and negative results for each assay in a time and resourceefficient manner. te: Dilution of ZeptoMetrix Respiratory Verification Panel organisms beyond levels proposed in these guidelines may lead to inconsistent results and is not recommended. The Simple Protocol can be followed to test a total of 28 pooled samples, providing 4 positive results and 24 negative results per assay. The number of samples tested per day should be determined by the individual laboratory. The testing scheme can be modified to run more samples per day based on the number of instruments configured on the FilmArray System. Pooled samples can be stored overnight (or up to 3 days) at refrigeration temperature (2 8 C) for subsequent testing to evaluate day-to-day variation. Table 3. Proposed Organism Pooling Scheme Organism Approximate volume Pool 1 Adenovirus Influenza A subtype H1 Pool 2 Influenza B Parainfluenza virus 4 Coronavirus OC43 Pool 3 Human rhinovirus/enterovirus Influenza A subtype H3 Coronavirus 229E Pool 4 Parainfluenza virus 1 Parainfluenza virus 2 Mycoplasma pneumoniae Pool 5 Influenza A subtype H1-2009 Parainfluenza virus 3 Pool 6 Respiratory Syncytial Virus Coronavirus NL63 Human Metapneumovirus Pool 7 Bordetella pertussis Chlamydia pneumoniae Coronavirus HKU1 Approximate Final Volume of Pool 1.2 ml 1.8 ml 1.8 ml 1.8 ml 1.2 ml 1.8 ml 1.8 ml An example Simple Protocol workflow is provided below. 3 P a g e FLM1-PRT-0060-08 Technical te

Simple Protocol Example The estimated total time for completion for this Simple Protocol verification example is 6 days for a FilmArray System configured with 1 instrument. A proposed organism pooling scheme is presented above in Table 3. Day 1 1. Prepare three sample pools (i.e. pools #1, #2, and #3 in Table 3 above) from ZeptoMetrix NATRVP-IDI control material. te: It is important to prepare only the number of sample pools that will be tested within 3 days of preparation. The suggestion to prepare 3 sample pools is based on testing 6 pouches per day. The number of samples prepared may be increased or decreased based on the laboratory s work schedule and number of instruments connected within a FilmArray System. a. Use a transfer pipette to remove the entire contents of the ZeptoMetrix organism vial (approximately ) and transfer to a new vial or tube. b. Repeat with the second (and third) organism to combine the appropriate organisms into a single vial or tube (approximately 1.2 ml total volume for two organisms or 1.8 ml for three organisms). te: Pools 1 and 5 contain 1.2 ml and will be used to test four pouches (approximately 0.3 ml for each pouch). If the volume of the sample is not sufficient to reach the 3 rd line of the Transfer Pipette when loading sample into your pouch, note the volume shortage and proceed with testing. c. Ensure the pooled sample is effectively mixed by vortexing prior to testing. 2. Test two samples from a single sample pool. The duplicate samples should be tested in a single day by different users. te: For each sample, follow instructions in the FilmArray Respiratory Panel Instruction Booklet and FilmArray Respiratory Panel Quick Guide for pouch preparation, pouch hydration, sample loading, and sample testing. 3. Repeat Step 2 for the remaining sample pools (i.e. pools #2 and #3) to be tested that day. 4. Refrigerate samples (2 8 C) for up to 3 days for the evaluation of day-to-day variation. Day 2 To evaluate day-to-day variation, test the remaining volume of the sample pools prepared on Day 1 by repeating Step 2 above. Day 3 Prepare 3 new sample pools (i.e. pools #4, #5, and #6) as described in Step 1. Test samples according to Step 2. Day 4 To evaluate day-to-day variation, test the samples prepared on Day 3 by repeating Step 2. 4 P a g e FLM1-PRT-0060-08 Technical te

Day 5-6 Repeat Steps 1 2 as above for any remaining sample pools (e.g. pool #7). Figure 1. Workflow for Simple Protocol Example 5 P a g e FLM1-PRT-0060-08 Technical te

VTM Protocol The VTM Protocol utilizes samples prepared by adding a single control organism (ZeptoMetrix NATRVP-IDI control organism) to an equal volume of Viral Transport Medium (VTM) sample matrix. The VTM Protocol can be followed to test a total of 76 samples, providing 4 positive results and 72 negative results per assay. The number of samples tested per day should be determined by the individual laboratory. The testing scheme can be modified to run more samples per day based on the number of instruments or modules configured on the FilmArray System. VTM samples can be stored overnight (or up to 3 days) at refrigeration temperature (2 8 C) for subsequent testing to evaluate day-to-day variation. To evaluate userto-user variation, multiple laboratory technicians may perform testing. Table 4. Proposed VTM Sample Preparation Scheme VTM Sample Approximate volume ZeptoMetrix NATRVP-IDI Control Organism VTM An example VTM Protocol workflow is provided below. VTM Protocol Example The estimated total time to completion for this VTM Protocol verification example is 14 days for a FilmArray System configured with 1 instrument. Day 1 1. Prepare three VTM Samples (i.e. sample #1, #2, #3) by mixing ZeptoMetrix NATRVP-IDI control material with VTM as proposed in Table 4. te: It is important to prepare only the number of samples that will be tested within 3 days of preparation. The suggestion to prepare 3 samples is based on testing 6 pouches per day. The number of samples prepared may be increased or decreased based on the laboratory s work schedule and number of instruments configured on the FilmArray System. a. Pipet of VTM into a sterile tube or vial. b. Use a transfer pipette to remove the entire contents of the ZeptoMetrix organism vial (approximately ) and add organism to the tube or vial containing VTM (total sample volume for one organism in VTM will be approximately 1.2 ml). c. Ensure the VTM sample is effectively mixed by vortexing prior to testing. 2. Test two samples (pouches) from a single VTM sample. The duplicate samples should be tested in a single day by different users. te: For each sample, follow instructions in the FilmArray Respiratory Panel Instruction Booklet and FilmArray Respiratory Panel Quick Guide for pouch preparation, pouch hydration, sample loading, and sample testing. 6 P a g e FLM1-PRT-0060-08 Technical te

3. Repeat Step 2 for the remaining samples to be tested that day. te: The approximate volume of VTM samples is 1.2 ml, which should be sufficient to test four pouches per sample (approximately 0.3 ml for each pouch). If the volume of the sample is not sufficient to reach the 3 rd line of the Transfer Pipette when loading sample into your pouch, note the volume shortage and proceed with testing. 4. Refrigerate samples (2 8 C) for up to 3 days for the evaluation of day-to-day variation. Day 2 To examine day-to-day variation, test the samples prepared on Day 1 by repeating Step 2. Day 3 4 Repeat Steps 1 4 for 3 additional samples (i.e. #4, #5, and #6). Day 5 6 Repeat Steps 1 4 for 3 additional samples (i.e. #7, #8, and #9). Day 7 8 Repeat Steps 1 4 for 2 additional samples (i.e. #10, #11, and #12). Day 9 10 Repeat steps 1 4 for the remaining samples (i.e. #13, #14 and #15). Day 11 12 Repeat steps 1 4 for the remaining samples (i.e. #16, #17, and #18). Day 13 14 Repeat steps 1 4 for the remaining samples (i.e. #19). 7 P a g e FLM1-PRT-0060-08 Technical te

Figure 2. Workflow for VTM Protocol Example 8 P a g e FLM1-PRT-0060-08 Technical te

Verification of loaner and repaired instruments If it becomes necessary to verify the performance of a loaner or repaired instrument, the following protocol may serve as a guideline, but should be verified by the Laboratory Director. 1. Select a few specimens and/or proficiency samples (any combination of positives and negatives) previously tested on the FilmArray Respiratory Panel (RP). The Laboratory Director should determine the appropriate number of samples to test. Two to six samples may be sufficient. Proficiency samples should not be pooled or diluted. 2. Test the selected specimens/samples on the loaner or repaired instrument and document the results. Technical Support Contact Information BioFire is dedicated to providing the best customer support available. If you have any questions or concerns about this process, please contact the FilmArray Technical Support team for assistance. BioFire Technical Support Email: support@biofiredx.com Phone: +1-801-736-6354, select Option 5 9 P a g e FLM1-PRT-0060-08 Technical te

FilmArray Respiratory Panel (RP) Verification Record Computer System Serial Number #: FilmArray RP Kit Part #: Lot #: Organism/Sample Source and Lot #: Organism Adenovirus Bordetella pertussis Chlamydia pneumoniae Coronavirus 229E Coronavirus NL63 Coronavirus OC43 Coronavirus HKU1 Human Metapneumovirus Human Rhinovirus/Enterovirus Influenza A subtype H1 Influenza A subtype H1-2009 Influenza A subtype H3 Influenza B Mycoplasma pneumoniae Parainfluenza virus 1 Parainfluenza virus 2 Parainfluenza virus 3 Parainfluenza virus 4 Respiratory Syncytial Virus Instrument Serial # Was the Organism Detected?. Positive. Negative. Days Tested. Users Patient Samples Tested? Reviewed by: Signature Date 10 P a g e FLM1-PRT-0060-08 Technical te